Upregulation of transforming growth factor-β (TGF-β) in podocytes is observed in patients with most progressive kidney diseases, indicating that TGF-β is the key regulator of ECM protein synthesis in podocytes. This evidence concerns the gene TGFB1 and kidney disorder.